Blakeley M P
Large-Scale Structures Group, Institut Laue-Langevin, 71 Avenue des Martyrs, Grenoble, 38000, France.
IUCrJ. 2016 Aug 31;3(Pt 5):296-297. doi: 10.1107/S2052252516013439. eCollection 2016 Sep 1.
Since drugs bind to their targets through directional H bonding and non-directional hydrophobic and electrostatic interactions, neutron crystallography can help guide structure-based drug design. This is illustrated by McKenna and co-workers [Aggarwal (2016), , , 319-325] who describe the room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor methazolamide to 2.2 Å resolution, and compare this with the previously determined room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor acetazolamide to 2.0 Å resolution [Fisher (2012). , 14726-14729].
由于药物通过定向氢键以及非定向疏水和静电相互作用与靶点结合,中子晶体学有助于指导基于结构的药物设计。麦肯纳及其同事 [阿加瓦尔(2016年),……,319 - 325页] 对此进行了说明,他们描述了人类碳酸酐酶II与临床抑制剂甲唑酰胺复合物在室温下的中子结构,分辨率达2.2 Å,并将其与之前测定的人类碳酸酐酶II与临床抑制剂乙酰唑胺复合物在室温下的中子结构(分辨率为2.0 Å)[费舍尔(2012年),……,14726 - 14729页] 进行了比较。